USD 105.92
(-2.22%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 445.88 Million USD | 20.9% |
2022 | 368.8 Million USD | 17.64% |
2021 | 313.51 Million USD | 31.42% |
2020 | 238.56 Million USD | 10.03% |
2019 | 216.82 Million USD | 42.34% |
2018 | 152.33 Million USD | 55.33% |
2017 | 98.07 Million USD | 66.87% |
2016 | 58.77 Million USD | 36.45% |
2015 | 43.07 Million USD | 66.15% |
2014 | 25.92 Million USD | 40.68% |
2013 | 18.42 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 126.45 Million USD | 0.64% |
2024 Q3 | 119.06 Million USD | -5.84% |
2024 Q1 | 125.65 Million USD | 8.76% |
2023 Q4 | 115.53 Million USD | 4.95% |
2023 FY | 445.88 Million USD | 20.9% |
2023 Q1 | 115.18 Million USD | 15.87% |
2023 Q2 | 105.09 Million USD | -8.76% |
2023 Q3 | 110.07 Million USD | 4.74% |
2022 Q2 | 93.69 Million USD | 11.94% |
2022 Q1 | 83.7 Million USD | 0.26% |
2022 Q4 | 99.4 Million USD | 8.04% |
2022 FY | 368.8 Million USD | 17.64% |
2022 Q3 | 92 Million USD | -1.8% |
2021 Q1 | 78.32 Million USD | 15.36% |
2021 Q4 | 83.48 Million USD | 5.1% |
2021 FY | 313.51 Million USD | 31.42% |
2021 Q3 | 79.43 Million USD | 9.9% |
2021 Q2 | 72.27 Million USD | -7.72% |
2020 Q4 | 67.89 Million USD | 16.12% |
2020 FY | 238.56 Million USD | 10.03% |
2020 Q3 | 58.46 Million USD | 5.24% |
2020 Q2 | 55.55 Million USD | -1.92% |
2020 Q1 | 56.64 Million USD | -9.97% |
2019 Q1 | 43.46 Million USD | -1.62% |
2019 FY | 216.82 Million USD | 42.34% |
2019 Q4 | 62.91 Million USD | 3.6% |
2019 Q3 | 60.73 Million USD | 17.18% |
2019 Q2 | 51.82 Million USD | 19.25% |
2018 Q4 | 44.17 Million USD | 16.55% |
2018 FY | 152.33 Million USD | 55.33% |
2018 Q3 | 37.9 Million USD | 0.65% |
2018 Q2 | 37.65 Million USD | 15.53% |
2018 Q1 | 32.59 Million USD | 4.82% |
2017 Q2 | 23.03 Million USD | 16.05% |
2017 Q3 | 24.09 Million USD | 4.63% |
2017 Q4 | 31.09 Million USD | 29.05% |
2017 FY | 98.07 Million USD | 66.87% |
2017 Q1 | 19.84 Million USD | 14.94% |
2016 Q4 | 17.26 Million USD | 21.9% |
2016 FY | 58.77 Million USD | 36.45% |
2016 Q3 | 14.16 Million USD | -0.78% |
2016 Q1 | 13.06 Million USD | -3.83% |
2016 Q2 | 14.27 Million USD | 9.25% |
2015 Q2 | 9.12 Million USD | 0.0% |
2015 Q4 | 13.58 Million USD | 22.45% |
2015 Q3 | 11.09 Million USD | 21.62% |
2015 Q1 | 9.12 Million USD | 24.38% |
2015 FY | 43.07 Million USD | 66.15% |
2014 Q4 | 7.33 Million USD | 0.0% |
2014 FY | 25.92 Million USD | 40.68% |
2013 FY | 18.42 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acutus Medical, Inc. | 11.22 Million USD | -3872.639% |
Cerus Corporation | 143.15 Million USD | -211.473% |
OrthoPediatrics Corp. | 137.01 Million USD | -225.421% |
PetVivo Holdings, Inc. | 11.36 Million USD | -3824.78% |
Talis Biomedical Corporation | 67.18 Million USD | -563.664% |
Vivos Therapeutics, Inc. | 24.94 Million USD | -1687.417% |
Inogen, Inc. | 236.08 Million USD | -88.868% |
Spectral AI, Inc. | 20.86 Million USD | -2037.121% |
Nano-X Imaging Ltd. | 55.99 Million USD | -696.273% |
CVRx, Inc. | 76.14 Million USD | -485.602% |
DIH Holding US, Inc. Warrants | 3.52 Million USD | -12538.591% |
Helius Medical Technologies, Inc. | 12.48 Million USD | -3470.254% |
Orthofix Medical Inc. | 667.42 Million USD | 33.193% |
Venus Concept Inc. | 80.47 Million USD | -454.065% |
Accelerate Diagnostics, Inc. | 56.57 Million USD | -688.096% |
Bioventus Inc. | 409.91 Million USD | -8.775% |
BrainsWay Ltd. | 28.01 Million USD | -1491.438% |
Envoy Medical, Inc. | 17.89 Million USD | -2391.278% |
electroCore, Inc. | 32.03 Million USD | -1292.055% |
IceCure Medical Ltd | 16.87 Million USD | -2542.149% |
Lucid Diagnostics Inc. | 42.43 Million USD | -950.832% |
Monogram Orthopaedics, Inc. | 17.63 Million USD | -2428.715% |
MaxCyte, Inc. | 84.84 Million USD | -425.534% |
NeuroOne Medical Technologies Corporation | 12.41 Million USD | -3492.47% |
Nexalin Technology, Inc. | 5.78 Million USD | -7612.533% |
PAVmed Inc | 64.82 Million USD | -587.814% |
Rapid Micro Biosystems, Inc. | 51.07 Million USD | -772.957% |
RxSight, Inc. | 103.85 Million USD | -329.359% |
Sight Sciences, Inc. | 126.44 Million USD | -252.624% |
SI-BONE, Inc. | 156.35 Million USD | -185.185% |
TELA Bio, Inc. | 84.18 Million USD | -429.641% |
TriSalus Life Sciences, Inc. | 70.05 Million USD | -536.475% |
Treace Medical Concepts, Inc. | 203.36 Million USD | -119.256% |
LivaNova PLC | 843.54 Million USD | 47.141% |
908 Devices Inc. | 68.08 Million USD | -554.949% |
Alphatec Holdings, Inc. | 483.59 Million USD | 7.798% |
Nemaura Medical Inc. | 7.13 Million USD | -6145.991% |
NeuroPace, Inc. | 75.29 Million USD | -492.182% |
LENSAR, Inc. | 33.33 Million USD | -1237.56% |
Apyx Medical Corporation | 51.01 Million USD | -773.984% |
Cutera, Inc. | 197.72 Million USD | -125.511% |
STRATA Skin Sciences, Inc. | 24.78 Million USD | -1699.318% |
BioSig Technologies, Inc. | 28.53 Million USD | -1462.878% |
Anika Therapeutics, Inc. | 191.47 Million USD | -132.871% |
ClearPoint Neuro, Inc. | 36.06 Million USD | -1136.52% |
Integra LifeSciences Holdings Corporation | 836.39 Million USD | 46.689% |
Axonics, Inc. | 270.2 Million USD | -65.021% |
Outset Medical, Inc. | 198.77 Million USD | -124.324% |
IRIDEX Corporation | 31.81 Million USD | -1301.55% |
PROCEPT BioRobotics Corporation | 180.21 Million USD | -147.415% |
IRadimed Corporation | 30.12 Million USD | -1380.237% |
Tivic Health Systems, Inc. | 8.53 Million USD | -5126.078% |
INVO Bioscience, Inc. | 7.85 Million USD | -5577.733% |
Telesis Bio, Inc. | 63.48 Million USD | -602.309% |
Viemed Healthcare, Inc. | 98.45 Million USD | -352.895% |
Varex Imaging Corporation | 224.8 Million USD | -98.349% |
Quipt Home Medical Corp. | 148.66 Million USD | -199.925% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -3703.54% |
Pulmonx Corporation | 112.68 Million USD | -295.688% |
Dynatronics Corporation | 9.9 Million USD | -4400.281% |
Modular Medical, Inc. | 17.52 Million USD | -2443.722% |
ReShape Lifesciences Inc. | 20.18 Million USD | -2108.793% |
Semler Scientific, Inc. | 38.94 Million USD | -1044.949% |
InMode Ltd. | 215.68 Million USD | -106.736% |
Bruker Corporation | 1.07 Billion USD | 58.576% |
Cytosorbents Corporation | 48.33 Million USD | -822.462% |
DexCom, Inc. | 1.69 Billion USD | 73.635% |
Align Technology, Inc. | 2.07 Billion USD | 78.53% |
Viveve Medical, Inc. | 22.17 Million USD | -1910.955% |
ZimVie Inc. | 275.12 Million USD | -62.067% |
Movano Inc. | 29.69 Million USD | -1401.815% |
Cytek Biosciences, Inc. | 137.27 Million USD | -224.824% |
Nexalin Technology, Inc. | 5.78 Million USD | -7612.533% |
DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -12538.591% |
Tandem Diabetes Care, Inc. | 600.92 Million USD | 25.799% |
Profound Medical Corp. | 33.6 Million USD | -1226.926% |
Insulet Corporation | 939.9 Million USD | 52.56% |
enVVeno Medical Corporation | 25.23 Million USD | -1666.737% |
Surmodics, Inc. | 98.69 Million USD | -351.776% |
iCAD, Inc. | 22.22 Million USD | -1906.25% |
Nuwellis, Inc. | 22.61 Million USD | -1871.826% |
Biotricity, Inc. | 17.18 Million USD | -2494.709% |
Aethlon Medical, Inc. | 12.27 Million USD | -3531.754% |
InspireMD, Inc. | 22.95 Million USD | -1842.871% |
PAVmed Inc. | 64.82 Million USD | -587.814% |
BIOLASE, Inc. | 34.66 Million USD | -1186.429% |
Beyond Air, Inc. | 61.7 Million USD | -622.673% |
FONAR Corporation | 28.6 Million USD | -1458.797% |
AxoGen, Inc. | 149.33 Million USD | -198.581% |
Vivani Medical, Inc. | 26.96 Million USD | -1553.584% |
Tactile Systems Technology, Inc. | 177.09 Million USD | -151.784% |
Inari Medical, Inc. | 448.59 Million USD | 0.603% |
UFP Technologies, Inc. | 58.08 Million USD | -667.596% |
QT Imaging Holdings, Inc. | 4.92 Million USD | -8948.809% |
Heart Test Laboratories, Inc. | 6.31 Million USD | -6957.116% |
Tenon Medical, Inc. | 16.96 Million USD | -2527.823% |
Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -5931.232% |
Co-Diagnostics, Inc. | 44.1 Million USD | -911.021% |
AdaptHealth Corp. | 1.07 Billion USD | 58.636% |
Sintx Technologies, Inc. | 15.2 Million USD | -2833.287% |
NanoVibronix, Inc. | 4.97 Million USD | -8866.197% |
Quanterix Corporation | 118.1 Million USD | -277.552% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -3703.54% |
Sensus Healthcare, Inc. | 14.44 Million USD | -2987.446% |
Pacific Biosciences of California, Inc. | 392.66 Million USD | -13.554% |
TransMedics Group, Inc. | 182.82 Million USD | -143.895% |
ReWalk Robotics Ltd. | 28.06 Million USD | -1488.772% |
NeuroMetrix, Inc. | 11.09 Million USD | -3917.404% |
Hyperfine, Inc. | 52.87 Million USD | -743.337% |
Establishment Labs Holdings Inc. | 172 Million USD | -159.233% |
Biomerica, Inc. | 6.97 Million USD | -6289.925% |
Bone Biologics Corporation | 9.42 Million USD | -4629.26% |
AVITA Medical, Inc. | 80.77 Million USD | -451.985% |
Bluejay Diagnostics, Inc. | 10.31 Million USD | -4224.311% |
Silk Road Medical, Inc | 186.35 Million USD | -139.266% |